comparemela.com

Michael Blaha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Diabetes, GLP-1, and Lipid Reduction

Michael Blaha, MD, highlights the potential of GLP-1 agonists in lowering LDL cholesterol, triglycerides, and body weight in patients with diabetes, presenting them as an additional option for reducing cardiovascular risk in this patient population.

Secondhand vape exposure dangerous for kids

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.